Home/Supreme Court/Teva Pharm. United States, Inc. v. Sandoz Inc.

Teva Pharm. United States, Inc. v. Sandoz Inc.

134 S. Ct. 1761, 188 L. Ed. 2d 592, 572 U.S. 1033, 82 U.S.L.W. 3566, 2014 WL 199529, 2014 U.S. LEXIS 2312
Procedural entryThis page is a short order in Teva Pharm. United States, Inc. v. Sandoz Inc.. Read the opinion of the Court — 135 S. Ct. 831 →
Supreme Court of the United States·Decided March 31, 2014·No. No. 13–854.·Published

Opinion

Case below, 723 F.3d 1363.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Teva Pharm. United States, Inc. v. Sandoz Inc., 134 S. Ct. 1761, 188 L. Ed. 2d 592, 572 U.S. 1033, 82 U.S.L.W. 3566, 2014 WL 199529, 2014 U.S. LEXIS 2312 (U.S. 2014).

134 S. Ct. 1761 (Teva Pharm. United States, Inc. v. Sandoz Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
723 F.3d 1363 (Federal Circuit, 2013)